Predictive markers of blood cytokine and chemokine in recurrent brain infarction

Journal of Interferon and Cytokine Research

Volumn 29, Issue 11, 2009, Pages 729-734

  Kuriyama, Nagato ^a   Mizuno, Toshiki ^a   Kita, Masakazu ^a   Nagakane, Yoshinari ^a   Hosomi, Akiko ^a   Harada, Sanae ^b   Takeda, Kazuo ^b   Ozasa, Kotaro ^a   Yamada, Kei ^a   Tokuda, Takahiko ^a   Watanabe, Yoshiyuki ^a   Nakagawa, Masanori ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO INDUSTRIAL HEALTH ASSOCIATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BLOOD VESSEL WALL; BRAIN INFARCTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; BRAIN INFARCTION; C-REACTIVE PROTEIN; CHEMOKINE CCL2; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE;

EID: 73649117464     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0012     Document Type: Article

References (28)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35-41.
2. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM. 1999. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19(6):1518-1525.
3. Arakelyan A, Petrkova J, Hermanova Z, Boyajyan A, Lukl J, Petrek M. 2005. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm 3:175-179.
4. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. 2006. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 114(15):1591-1598.
5. Braunersreuther V, Mach F, Steffens S. 2007. The specific role of chemokines in atherosclerosis. Thromb Haemost 97(5):714-721.
6. Charo IF, Taubman MB. 2004. Chemokines in the pathogenesis of vascular disease. Circ Res 95(9):858-866.
7. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. 2003. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107(5):690-695.
8. Economou E, Tousoulis D, Katinioti A, Stefanadis C, Trikas A, Pitsavos C, Tentolouris C, Toutouza MG, Toutouzas P. 2001. Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty. Int J Cardiol 80(1):55-60.
9. Egashira K. 2003. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41(3):834-841.
10. Han KH, Hong KH, Park JH, Ko J, Kang DH, Choi KJ, Hong, MK, Park SW, Park SJ. 2004. C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 109(21):2566-2571.
11. Hansson GK. 1999. Inflammation and immune response in atherosclerosis. Curr Atheroscler Rep 1(2):150-155.
12. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. 1998. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 98(3):224-233.
13. Lash GE, Scaife PJ, Innes BA, Otun HA, Robson SC, Searle RF, Bulmer JN. 2006. Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. J Immunol Methods 309(1-2):205-208.
14. Libby P. 2002. Inflammation in atherosclerosis. Nature 420(6917): 868-874.
15. Libby P, Ridker PM. 2004. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116(suppl 6A):9-16.
16. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, Ballantyne CM. 2005. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem 51(7):1102-1109.
17. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169(4):1485-1490.
18. Pasceri V, Cheng JS, Willerson JT, Yeh ET. 2001. Modulation of C-reactive protein-mediated monocyte chemoattractant protein- 1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103(21):2531-2534.
19. Patel S, Celermajer DS, Bao S. 2008. Atherosclerosis-Underlying inflammatory mechanisms and clinical implications. Int J Biochem Cell Biol 40(4):576-580.
20. Rhyne PW, Scull JD, Stiles LM, Eisinger DP. 2003. Analysis of apoptotic cells using Beadlyte suspension arrays. Biotechniques 35(3):624-629.
21. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423): 801-809.
22. Ross R. 1999. Atherosclerosis-an inflammatory disease. N Engl J Med 340(2):115-126.
23. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro J, D'Agostino RB, Franzblau C, Wilson PW. 2001. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32(11):2575-2579.
24. Sheikine Y, Hansson GK. 2004. Chemokines and atherosclerosis. Ann Med 36(2):98-118.
25. Sheikine YA, Hansson GK. 2006. Chemokines as potential therapeutic targets in atherosclerosis. Curr Drug Targets 7(1):13-27.
26. Wang X, Yue TL, Barone FC, Feuerstein GZ. 1995. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26(4):661-666.
27. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88(12):5252-5256.
28. Yoldas T, Gonen M, Godekmerdan A, Ilhan F, Bayram E. 2007. The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic stroke. Mediators Inflamm 2007:15929.